Evidence map›Paper›PMID 30883216›Full record

ReviewAnnual review of cell and developmental biology2019

Non-Antibody-Secreting Functions of B Cells and Their Contribution to Autoimmune Disease.

Andrew Getahun, John C Cambier

Open access · greenAbstract readReview
In one paragraph

Review in Annual review of cell and developmental biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Turncoat antibodies unmasked in a model of autoimmune demyelination: From biology to therapy.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patients.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. HeterozygousScience immunology · 2021
    Observational
  18. Article
  19. Review
  20. Frontiers in cellular and infection microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andrew GetahunDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado 80045, USA; email: andrew.getahun@ucdenver.edu.
John C CambierDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado 80045, USA; email: andrew.getahun@ucdenver.edu.
University of Colorado Denver · US

Funding

SIGNAL TRANSDUCTION IN B CELL ACTIVATIONR01AG013983 · NIA · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 1996 to 2010
$3.0M
Autoimmunity risk alleles compromising B cell anergyR01AI124487 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 2016 to 2020
$2.5M
Insulin Specific T and B cells in Type 1 DiabetesDP3DK110845 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C, MICHELS, AARON W · 2016 to 2016
$1.7M
Perturbation of B cell anergy in T1DR21AI124488 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 2016 to 2017
$428k
NIAID NIH HHS R01 AI124487NIAID NIH HHS R21 AI124488NIA NIH HHS R01 AG013983NIDDK NIH HHS DP3 DK110845
6 · The paper itself

Abstract

B cells play multiple important roles in the pathophysiology of autoimmune disease. Beyond producing pathogenic autoantibodies, B cells can act as antigen-presenting cells and producers of cytokines, including both proinflammatory and anti-inflammatory cytokines. Here we review our current understanding of the non-antibody-secreting roles that B cells may play during development of autoimmunity, as learned primarily from reductionist preclinical models. Attention is also given to concepts emerging from clinical studies using B cell depletion therapy, which shed light on the roles of these mechanisms in human autoimmune disease.

Indexed as

AnimalsAutoimmune DiseasesAutoimmunityB-Lymphocyte SubsetsCytokinesDisease Models, AnimalHumansInflammationCytokinesantigen presentationautoimmuneB cell depletionB cellscytokineT cells

Identifiers

PMID30883216
PMCPMC9553839
OpenAlexW2924262306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.